Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABRAFENIB Cause Multiple organ dysfunction syndrome? 49 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Multiple organ dysfunction syndrome have been filed in association with DABRAFENIB (Tafinlar). This represents 0.3% of all adverse event reports for DABRAFENIB.

49
Reports of Multiple organ dysfunction syndrome with DABRAFENIB
0.3%
of all DABRAFENIB reports
38
Deaths
27
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From DABRAFENIB?

Of the 49 reports, 38 (77.6%) resulted in death, 27 (55.1%) required hospitalization, and 5 (10.2%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 49 reports have been filed with the FAERS database.

What Other Side Effects Does DABRAFENIB Cause?

Pyrexia (3,788) Death (2,740) Malignant neoplasm progression (1,667) Fatigue (1,328) Nausea (1,300) Chills (1,235) Rash (1,078) Vomiting (907) Diarrhoea (901) Headache (697)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which DABRAFENIB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

DABRAFENIB vs DABRAFENIB\TRAMETINIB DABRAFENIB vs DACARBAZINE DABRAFENIB vs DACLATASVIR DABRAFENIB vs DACLIZUMAB DABRAFENIB vs DACOMITINIB

Related Pages

DABRAFENIB Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome DABRAFENIB Demographics